SCHEMBL17036997

SCHEMBL17036997

CCOCC(O)COc1ccc(C(C)CC)cc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.53
▸ TSHR P16473 1/20 0.53
▸ KMT2A Q03164 4/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ MAPT P10636 3/20 0.45
▸ POLB P06746 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ GAA P10253 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ SLC6A2 P23975 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2626902 0.87 ALDH1A1 (0.58) ALDH1A1TSHRKMT2AMEN1TDP1
SCHEMBL11018105 0.86 KMT2A (0.49) ALDH1A1TSHRKMT2AMEN1TDP1
SCHEMBL17036996 0.84 ALDH1A1 (0.55) ALDH1A1TSHRKMT2AMEN1TDP1
SCHEMBL27709852 0.82 ALDH1A1 (0.60) ALDH1A1TSHRKMT2AMEN1TDP1
SCHEMBL2108251 0.81 ALDH1A1 (0.44) ALDH1A1TSHRKMT2AMEN1TDP1
SCHEMBL12587683 0.80 ALDH1A1 (0.57) ALDH1A1TSHRKMT2AMEN1TDP1
SCHEMBL5494961 0.79 TDP1 (0.55) ALDH1A1TSHRKMT2AMEN1TDP1
SCHEMBL15140443 0.79 MEN1 (0.51) ALDH1A1TSHRKMT2AMEN1TDP1
SCHEMBL13328780 0.79 KDM4E (0.56) ALDH1A1TSHRKMT2AMEN1MAPT
SCHEMBL11959217 0.78 LMNA (0.58) TSHRKMT2AMEN1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150238401-A1 PROPYL-PHENYL-ETHER DERIVATIVE, AND MELANOGENESIS INHIBITOR, SKIN-LIGHTENING AGENT, ANTIMICROBIAL AGENT AND COSMETIC CONTAINING SAID PROPYL-PHENYL-ETHER DERIVATIVE SEIWA KASEI COMPANY, LIMITED (JP) 2015-08-27 — — US disclosed
US-20150238401-A1 PROPYL-PHENYL-ETHER DERIVATIVE, AND MELANOGENESIS INHIBITOR, SKIN-LIGHTENING AGENT, ANTIMICROBIAL AGENT AND COSMETIC CONTAINING SAID PROPYL-PHENYL-ETHER DERIVATIVE SEIWA KASEI COMPANY, LIMITED (JP) 2015-08-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150238401-A1 PROPYL-PHENYL-ETHER DERIVATIVE, AND MELANOGENESIS INHIBITOR, SKIN-LIGHTENING AGENT, ANTIMICROBIAL AGENT AND COSMETIC CONTAINING SAID PROPYL-PHENYL-ETHER DERIVATIVE TYR, MITF, MC1R ALDH1A1 2374/4885TSHR 873/4885KMT2A 778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback